Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPolar Capital Regulatory News (POLR)

Share Price Information for Polar Capital (POLR)

Share Price is delayed by 15 minutes
Get Live Data
888.00    2.00 (0.23%)
Bid:
886.00
Ask:
888.00
Spread: 2.00 (0.226%)
Market Cap: £836.02m
POLR Live PriceLast checked at - London Stock Exchange

Intraday Polar Capital Share Chart

Issue of Equity

31 Mar 2016 09:28

RNS Number : 6840T
Polar Capital Holdings PLC
31 March 2016
 

31 March 2016

Polar Capital Holdings plc

Issue of Equity

Polar Capital Holdings plc ("Polar Capital" or the "Company") announces that today 417,088 ordinary shares of 2.5 pence each in the Company have been allotted and issued in respect of the previously announced (30 September 2013) crystallization of the European Conviction Fund. Application has been made for the new ordinary shares to be admitted to trading on AIM and dealings are expected to commence on 5 April 2016.

 

This issue is the fourth and final allotment of shares in respect of the European Conviction Fund.

 

The Company's current issued share capital is 90,798,923 ordinary shares and following admission of the New Shares, the total number of ordinary shares allotted and in issue will be 91,216,011.

 

Background

As set out at the time of the Company's admission to AIM, Polar Capital has structured its fund management operations in such a way that the fund management teams are placed in separate business units. Each business unit is a separate profit centre and the fund managers responsible receive an annual payment which comprises a share of their unit's core operating profit (operating profit before performance fees and related distributions) and performance fees.

 

In addition each fund management team is offered the prospect of an interest in the capital of the Company through the purchase of an individual class of preference shares in Polar Capital Partners Limited, a wholly owned subsidiary of the Company. These preference shares have been structured in such a way as to become convertible upon the occurrence of certain events know as crystallisation events into cash or, at the option of the Company, ordinary shares in the Company at a ratio that is intended to be earnings enhancing for the Group.

 

Upon the occurrence of a crystallisation event the fund managers concerned cease to be eligible to receive their share of the business unit's core operating profit and simultaneously going forward receive a reduced interest in their performance fees.

Enquiries:

Polar Capital Holdings

Canaccord Genuity - Nomad and Joint Broker

Tim Woolley (CEO)

Roger Lambert

John Mansell (CFO)

Simon Bridges

Kit Stephenson

Tel: +44 (0)20 7227 2700

+44 (0)20 7523 8350

Peel Hunt - Joint Broker

Guy Wiehahn

Tel: +44 (0)20 7418 8893

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOELIFFTVDILVIR
Date   Source Headline
1st Nov 20187:00 amRNSTotal Voting Rights
25th Oct 20185:26 pmRNSIssue of Equity
24th Oct 20184:52 pmRNSDirector/PDMR Shareholding
17th Oct 20185:49 pmRNSIssue of Equity
15th Oct 201812:38 pmRNSForm 8.3 - Jardine Lloyd Thompson Group Plc
12th Oct 20182:52 pmRNSForm 8.3 - Jardine Lloyd Thompson Group Plc
11th Oct 20184:42 pmRNSIssue of Equity
11th Oct 20187:01 amRNSCrystallisation of business unit & issue of shares
11th Oct 20187:00 amRNSAUM Update
3rd Oct 201810:24 amRNSForm 8.3 - Jardine Lloyd Thompson Group Plc
19th Sep 201811:52 amRNSForm 8.3 - Jardine Lloyd Thompson Group
18th Sep 201812:02 pmRNSForm 8.3 - Realm Therapeutics PLC
17th Aug 20189:27 amRNSDirectorate Change
6th Aug 20187:00 amRNSBlock listing Interim Review
1st Aug 20187:00 amRNSTotal Voting Rights
31st Jul 20185:57 pmRNSIssue of Equity
31st Jul 201811:29 amRNSDirector/PDMR Shareholding
25th Jul 20183:38 pmRNSDirectorate Change
25th Jul 20183:26 pmRNSResult of AGM
19th Jul 201811:13 amRNSForm 8.3 - Consort Medical Plc
18th Jul 20184:21 pmRNSDirector/PDMR Shareholding
18th Jul 201811:50 amRNSForm 8.3 - Consort Medical Plc
17th Jul 201810:58 amRNSForm 8.3 - Consort Medical Plc
16th Jul 20183:44 pmRNSDirector/PDMR Shareholding
12th Jul 201811:50 amRNSForm 8.3 - Consort Medical Plc
12th Jul 20187:00 amRNSAuM Update
11th Jul 201811:06 amRNSForm 8.3 - Consort Medical Plc
3rd Jul 20186:27 pmRNSHolding(s) in Company
3rd Jul 20186:20 pmRNSIssue of Equity
3rd Jul 201812:07 pmRNSForm 8.3 - Consort Medical Plc
2nd Jul 201810:23 amRNSTotal Voting Rights
29th Jun 20187:00 amRNSBlock Listing Application
28th Jun 20185:55 pmRNSAnnual Financial Report
25th Jun 20187:00 amRNSGroup Audited Results for year ended 31 March 2018
11th Jun 201811:27 amRNSNet Asset Value(s)
1st Jun 20187:41 amRNSTotal Voting Rights
24th May 201810:59 amRNSDirector/PDMR Shareholding
24th May 20189:35 amRNSIssue of Equity
23rd May 201811:00 amRNSNotice of Results
23rd May 20189:37 amRNSIssue of Equity
18th May 20181:02 pmRNSIssue of Equity
16th May 20185:49 pmRNSIssue of Equity
11th May 20187:00 amRNSIssue of Equity
10th May 20189:56 amRNSDirector/PDMR Shareholding
1st May 20183:52 pmRNSIssue of Equity
12th Apr 20187:00 amRNSAuM Update
5th Apr 20187:00 amRNSIssue of Equity
20th Mar 20182:19 pmRNSIssue of Equity
5th Feb 20183:15 pmRNSBlock listing Interim Review
18th Jan 20183:02 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.